The global nasal drug delivery technology market was valued at USD 71.89 billion in 2022, expanding at a CAGR of 7.45% from 2023 to 2030. Growing awareness regarding nasal products is one of the major factors driving the market.
The growing geriatric population is expected to positively drive the overall market. In 2020, there were 727 million people worldwide who are 65 years of age or older, according to a report by the United Nations Department of Economic and Social Affairs. The number of elderly people worldwide is expected to depict more than double growth during the next three decades, reaching over 1.5 billion in 2050. Between 2020 and 2050, the geriatric population is expected to grow in size across the nation. Globally, it is anticipated that the percentage of people 65 and older will rise from 9.3% in 2020 to almost 16.0% in 2050.
Moreover, increasing patient preference for nasal products owing to their efficacy and easy administration is anticipated to fuel the nasal drug delivery systems market growth. For instance, in February 2021, Nanoform Finland and Herantis announced their agreement on nasal drug delivery to the brain by creating a non-exclusive agreement for formulation proof of concept initiatives.
Additionally, the nasal drug delivery method is widely used to treat brain disorders as it offers a route for systemic circulation of drugs, low bioavailability, fast absorption, and desirable action. In this respect, nasal drug delivery could serve as an attractive non-invasive delivery method for CNS drugs. Moreover, nasal delivery of substances such as peptoids, raltitrexed, 5-fluorouracil telomerase inhibitors, and methotrexate has been shown to reduce brain tumors and increase survival in animal models.
Nasal Drug Delivery Technology Market Report Highlights
- Based on dosage form, the nasal spray segment held the largest revenue share in 2022 owing to the increasing incidence of infections and allergic rhinitis and growing demand for generic nasal spray drugs
- By container type, the non-pressurized containers segment dominated the market in 2022. Nasal drops, nasal powder, and nasal gel usually come in these containers. Growing demand for related products is expected to propel the segment growth over the forecast period
- In terms of therapeutic application, the rhinitis segment held the largest share in 2022 due to the availability of related products for its treatment
- By distribution channel, the retail pharmacies segment accounted for the largest share in 2022 owing to easy availability and convenience
- North America held the largest market share in 2022 owing to the rising prevalence of asthma and chronic obstructive pulmonary disease and the widespread usage of early treatment measures
Table of Contents
Chapter 1. Methodology and Scope1.1 Market Segmentation & Scope
1.1.1 Dosage Form
1.1.2 Container Type
1.1.3 Therapeutic Application
1.1.3 Distribution Channel
1.1.5 Regional Scope
1.1.6 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.3 Data for Primary Interviews in Europe
1.3.5.4 Data for Primary Interviews in APAC
1.3.5.6 Data for Primary Interviews in Latin America
1.3.5.8 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Nasal Drug Delivery Technology Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Rising patient preference for nasal drug delivery
3.2.1.2 Growing incidence of chronic diseases
3.2.1.3 Increasing adoption of self-administration practices
3.2.1.4 Development of off-patent drugs for respiratory care
3.2.2 Market Restraint Analysis
3.2.2.1 Complications associated with the overuse of nasal sprays
3.2.2.2 Stringent regulatory framework
3.3 Nasal Drug Delivery Technology: Market Analysis Tools
3.3.1 SWOT Analysis by PESTEL
3.3.2 Industry Analysis - Porter’s Five Forces
3.4 Impact of COVID-19
3.4.1 COVID-19 Impact analysis
3.4.2 Impact on market players
Chapter 4 Nasal Drug Delivery Technology Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Billion)
4.1 Definitions and Scope
4.2 Dosage Form Market Share Analysis
4.3 Segment Dashboard
4.4 Nasal Drug Delivery Technology Market by Dosage Form
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1 Nasal Spray
4.5.1.1 Nasal Spray Market Estimates and Forecast, 2018 - 2030 (USD Billion)
4.5.2 Nasal Drop
4.5.2.1 Nasal Drop Market Estimates and Forecast, 2018 - 2030 (USD Billion)
4.5.3 Nasal Gel
4.5.3.1 Nasal Gel Market Estimates and Forecast, 2018 - 2030 (USD Billion)
4.5.4 Nasal Powder
4.5.4.1 Nasal Powder Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Chapter 5 Nasal Drug Delivery Technology Market: Segment Analysis, By Container Type, 2018 - 2030 (USD Billion)
5.1 Definitions and Scope
5.2 Container Type Market Share Analysis
5.3 Segment Dashboard
5.4 Nasal Drug Delivery Technology Market by Container Type
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1 Pressurized Containers
5.5.1.1 Pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)
5.5.2 Non-pressurized Containers
5.5.2.1 Non-pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Chapter 6 Nasal Drug Delivery Technology Market: Segment Analysis, By Therapeutic Application, 2018 - 2030 (USD Billion)
6.1 Definitions and Scope
6.2 Therapeutic Application Market Share Analysis
6.3 Segment Dashboard
6.4 Nasal Drug Delivery Technology Market by Therapeutic Application
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1 Nasal Congestion
6.5.1.1 Nasal Congestion Market Estimates and Forecast, 2018 - 2030 (USD Billion)
6.5.2 Rhinitis
6.5.2.1 Rhinitis Market Estimates and Forecast, 2018 - 2030 (USD Billion)
6.5.3 Asthma
6.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
6.5.4 Others
6.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Chapter 7 Nasal Drug Delivery Technology Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Billion)
7.1 Definitions and Scope
7.2 Distribution Channel Market Share Analysis
7.3 Segment Dashboard
7.4 Nasal Drug Delivery Technology Market by Distribution Channel
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1 Hospital Pharmacies
7.5.1.1 Hospital Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
7.5.2 Retail Pharmacies
7.5.2.1 Retail Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
7.5.3 Online Pharmacies
7.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
7.5.4 Others
7.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Chapter 8 Nasal Drug Delivery Technology Market: Regional Market Analysis, 2018 - 2030 (USD Billion)
8.1 Regional Market Dashboard
8.2 Definitions and Scope
8.3 Regional Market Share Analysis
8.4 North America
8.4.1 North America market estimates and forecast, 2018 - 2030
8.4.2 U.S.
8.4.2.1 U.S. market estimates and forecast, 2018 - 2030
8.4.3 Canada
8.4.3.1 Canada market estimates and forecast, 2018 - 2030
8.5 Europe
8.5.1 Europe market estimates and forecast, 2018 - 2030
8.5.2 U.K.
8.5.2.1 U.K. market estimates and forecast, 2018 - 2030
8.5.3 Germany
8.5.3.1 Germany market estimates and forecast, 2018 - 2030
8.5.4 France
8.5.4.1 France market estimates and forecast, 2018 - 2030
8.5.5 Italy
8.5.5.1 Italy market estimates and forecast, 2018 - 2030
8.5.6 Spain
8.5.6.1 Spain market estimates and forecast, 2018 - 2030
8.5.7 Sweden
8.5.7.1 Sweden market estimates and forecast, 2018 - 2030
8.5.8 Denmark
8.5.8.1 Denmark market estimates and forecast, 2018 - 2030
8.5.9 Norway
8.5.9.1 Norway market estimates and forecast, 2018 - 2030
8.6 Asia Pacific
8.6.1 Asia Pacific market estimates and forecast, 2018 - 2030
8.6.2 Japan
8.6.2.1 Japan market estimates and forecast, 2018 - 2030
8.6.3 China
8.6.3.1 China market estimates and forecast, 2018 - 2030
8.6.4 India
8.6.4.1 India market estimates and forecast, 2018 - 2030
8.6.5 Australia
8.6.5.1 Australia market estimates and forecast, 2018 - 2030
8.6.6 South Korea
8.6.6.1 South Korea market estimates and forecast, 2018 - 2030
8.6.7 Thailand
8.6.7.1 Thailand market estimates and forecast, 2018 - 2030
8.7 Latin America
8.7.1 Latin America market estimates and forecast, 2018 - 2030
8.7.2 Mexico
8.7.2.1 Mexico market estimates and forecast, 2018 - 2030
8.7.3 Brazil
8.7.3.1 Brazil market estimates and forecast, 2018 - 2030
8.7.4 Argentina
8.7.4.1 Argentina market estimates and forecast, 2018 - 2030
8.8 Middle East and Africa
8.8.1 Middle East and Africa market estimates and forecast, 2018 - 2030
8.8.2 South Africa
8.8.2.1 South Africa market estimates and forecast, 2018 - 2030
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030
8.8.4 UAE
8.8.4.1 UAE market estimates and forecast, 2018 - 2030
8.8.5 Kuwait
8.8.5.1 Kuwait market estimates and forecast, 2018 - 2030
Chapter 9 Nasal Drug Delivery Technology Market - Competitive Analysis
9.1 Kind of Competition
9.2 Concentration of Market Players
9.3 Company Market Share Analysis
9.4 Categorization based on the Company’s Vision
9.5 Company Profiles
9.5.1 GlaxoSmithKline PLC
9.5.1.1 Company overview
9.5.1.2 Financial performance
9.5.1.3 Product benchmarking
9.5.1.4 Strategic initiatives
9.5.2 AstraZeneca PLC
9.5.2.1 Company overview
9.5.2.2 Financial performance
9.5.2.3 Product benchmarking
9.5.2.4 Strategic initiatives
9.5.3 Pfizer, Inc.
9.5.3.1 Company overview
9.5.3.2 Financial performance
9.5.3.3 Productbenchmarking
9.5.3.4 Strategic initiatives
9.5.4 OptiNose, Inc.
9.5.4.1 Company overview
9.5.4.2 Financial performance
9.5.4.3 Product benchmarking
9.5.4.4 Strategic initiatives
9.5.5 Becton, Dickinson and Company
9.5.5.1 Company overview
9.5.5.2 Financial performance
9.5.5.3 Product benchmarking
9.5.5.4 Strategic initiatives
9.5.6 Promius Pharma, LLC
9.5.6.1 Company overview
9.5.6.2 Financial performance
9.5.6.3 Product benchmarking
9.5.6.4 Strategic initiatives
9.5.7 Cadila Pharmaceuticals Ltd.
9.5.7.1 Company overview
9.5.7.2 Financial performance
9.5.7.3 Product benchmarking
9.5.7.4 Strategic initiatives
9.5.8 B.F. Ascher & Company, Inc.
9.5.8.1 Company overview
9.5.8.2 Financial performance
9.5.8.3 Product benchmarking
9.5.8.4 Strategic initiatives
9.5.9 PendoPharm, Inc.
9.5.9.1 Company overview
9.5.9.2 Financial performance
9.5.9.3 Product benchmarking
9.5.9.4 Strategic initiatives
9.5.10 Douglas Pharmaceuticals Ltd.
9.5.10.1 Company overview
9.5.10.2 Financial performance
9.5.10.3 Product benchmarking
9.5.10.4 Strategic initiatives
9.5.11 ENT Technologies Pty. Ltd.
9.5.11.1 Company overview
9.5.11.2 Financial performance
9.5.11.3 Product benchmarking
9.5.11.4 Strategic initiatives
9.5.12 ENT Technologies Pty. Ltd.
9.5.12.1 Company overview
9.5.12.2 Financial performance
9.5.12.3 Product benchmarking
9.5.12.4 Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
Table 3 North America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 4 North America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 5 North America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 6 North America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 7 U.S. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 8 U.S. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 9 U.S. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 10 U.S. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 11 Canada nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 12 Canada nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 13 Canada nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 14 Canada nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 15 Europe nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
Table 16 Europe nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 17 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 18 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 19 Europe nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 20 Germany nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 21 Germany nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 22 Germany nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 23 Germany nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 24 U.K. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 25 U.K. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 26 U.K. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 27 U.K. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 28 France nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 29 France nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 30 France nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 31 France nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 32 Italy nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 33 Italy nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 34 Italy nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 35 Italy nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 36 Spain nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 37 Spain nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 38 Spain nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 39 Spain nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 40 Sweden nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 41 Sweden nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 42 Sweden nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 43 Sweden nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 44 Denmark nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 45 Denmark nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 46 Denmark nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 47 Denmark nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 48 Norway nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 49 Norway nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 50 Norway nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 51 Norway nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 52 Asia Pacific nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
Table 53 Asia Pacific nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 54 Asia Pacific nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 55 Asia Pacific nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 56 Asia Pacific nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 57 China nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 58 China nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 59 China nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 60 China nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 61 Japan nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 62 Japan nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 63 Japan nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 64 Japan nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 65 India nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 66 India nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 67 India nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 68 India nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 69 Australia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 70 Australia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 71 Australia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 72 Australia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 73 South Korea nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 74 South Korea nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 75 South Korea nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 76 South Korea nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 77 Thailand nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 78 Thailand nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 79 Thailand nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 80 Thailand nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 81 Latin America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
Table 82 Latin America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 83 Latin America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 84 Latin America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 85 Latin America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 86 Brazil nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 87 Brazil nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 88 Brazil nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 89 Brazil nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 90 Mexico nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 91 Mexico nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 92 Mexico nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 93 Mexico nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 94 Argentina nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 95 Argentina nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 96 Argentina nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 97 Argentina nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 98 Middle East and Africa nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
Table 99 Middle East and Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 100 Middle East and Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 101 Middle East and Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 102 Middle East and Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 103 South Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 104 South Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 105 South Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 106 South Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 107 Saudi Arabia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 108 Saudi Arabia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 109 Saudi Arabia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 110 Saudi Arabia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 111 UAE nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 112 UAE nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 113 UAE nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 114 UAE nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 115 Kuwait nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
Table 116 Kuwait nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
Table 117 Kuwait nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
Table 118 Kuwait nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
List of Figures
FIG. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Nasal drug delivery technology: market outlook
Fig. 14 Nasal drug delivery technology competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Nasal drug delivery technology driver impact
Fig. 20 Nasal drug delivery technology restraint impact
Fig. 21 Nasal drug delivery technology strategic initiatives analysis
Fig. 22 Nasal drug delivery technology: dosage form movement analysis
Fig. 23 Nasal drug delivery technology: dosage form outlook and key takeaways
Fig. 24 Nasal spray market estimates and forecast, 2018 - 2030
Fig. 25 Nasal drop market estimates and forecast, 2018 - 2030
Fig. 26 Nasal gel market estimates and forecast, 2018 - 2030
Fig. 27 Nasal powder market estimates and forecast, 2018 - 2030
Fig. 28 Nasal drug delivery technology: container type movement analysis
Fig. 29 Nasal drug delivery technology: container type outlook and key takeaways
Fig. 30 Pressurized containers market estimates and forecast, 2018 - 2030
Fig. 31 Non-pressurized containers market estimates and forecast, 2018 - 2030
Fig. 32 Nasal drug delivery technology: therapeutic application movement analysis
Fig. 33 Nasal drug delivery technology: therapeutic application outlook and key takeaways
Fig. 34 Nasal congestion market estimates and forecast, 2018 - 2030
Fig. 35 Rhinitis market estimates and forecast, 2018 - 2030
Fig. 36 Asthma market estimates and forecast, 2018 - 2030
Fig. 37 Others market estimates and forecast, 2018 - 2030
Fig. 38 Nasal drug delivery technology: distribution channel movement analysis
Fig. 39 Nasal drug delivery technology: distribution channel outlook and key takeaways
Fig. 40 Hospital pharmacies market estimates and forecast, 2018 - 2030
Fig. 41 Retail pharmacies market estimates and forecast, 2018 - 2030
Fig. 42 Online pharmacies market estimates and forecast, 2018 - 2030
Fig. 43 Global nasal drug delivery technology market: regional movement analysis
Fig. 44 Global nasal drug delivery technology market: regional outlook and key takeaways
Fig. 45 Global market shares and leading players
Fig. 46 North America market share and leading players
Fig. 47 Europe market share and leading players
Fig. 48 Asia Pacific market share and leading players
Fig. 49 Latin America market share and leading players
Fig. 50 Middle East & Africa market share and leading players
Fig. 51 North America: SWOT
Fig. 52 Europe SWOT
Fig. 53 Asia Pacific SWOT
Fig. 54 Latin America SWOT
Fig. 55 MEA SWOT
Fig. 56 North America, by country
Fig. 57 North America
Fig. 58 North America market estimates and forecast, 2018 - 2030
Fig. 59 U.S.
Fig. 60 U.S. market estimates and forecast, 2018 - 2030
Fig. 61 Canada
Fig. 62 Canada market estimates and forecast, 2018 - 2030
Fig. 63 Europe
Fig. 64 Europe. market estimates and forecast, 2018 - 2030
Fig. 65 U.K.
Fig. 66 U.K. market estimates and forecast, 2018 - 2030
Fig. 67 Germany
Fig. 68 Germany market estimates and forecast, 2018 - 2030
Fig. 69 France
Fig. 70 France market estimates and forecast, 2018 - 2030
Fig. 71 Italy
Fig. 72 Italy market estimates and forecast, 2018 - 2030
Fig. 73 Spain
Fig. 74 Spain market estimates and forecast, 2018 - 2030
Fig. 75 Sweden
Fig. 76 Sweden market estimates and forecast, 2018 - 2030
Fig. 77 Denmark
Fig. 78 Denmark market estimates and forecast, 2018 - 2030
Fig. 79 Norway
Fig. 80 Norway market estimates and forecast, 2018 - 2030
Fig. 81 Asia Pacific
Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 83 China
Fig. 84 China market estimates and forecast, 2018 - 2030
Fig. 85 Japan
Fig. 86 Japan market estimates and forecast, 2018 - 2030
Fig. 87 India
Fig. 88 India market estimates and forecast, 2018 - 2030
Fig. 89 Australia
Fig. 90 Australia market estimates and forecast, 2018 - 2030
Fig. 91 South Korea
Fig. 92 South Korea market estimates and forecast, 2018 - 2030
Fig. 93 Thailand
Fig. 94 Thailand market estimates and forecast, 2018 - 2030
Fig. 95 Latin America
Fig. 96 Latin America market estimates and forecast, 2018 - 2030
Fig. 97 Brazil
Fig. 98 Brazil market estimates and forecast, 2018 - 2030
Fig. 99 Mexico
Fig. 100 Mexico market estimates and forecast, 2018 - 2030
Fig. 101 Argentina
Fig. 102 Argentina market estimates and forecast, 2018 - 2030
Fig. 103 Middle East and Africa
Fig. 104 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 105 Saudi Arabia
Fig. 106 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 107 South Africa
Fig. 108 South Africa market estimates and forecast, 2018 - 2030
Fig. 109 UAE
Fig. 110 UAE market estimates and forecast, 2018 - 2030
Fig. 111 Kuwait
Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
Fig. 113 Participant categorization- nasal drug delivery technology market
Fig. 114 Market share of key market players- nasal drug delivery technology market
Companies Mentioned
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- B.F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | December 2022 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 76.89 Billion |
| Forecasted Market Value ( USD | $ 127.12 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
